Your browser doesn't support javascript.
loading
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study.
Bai, Xue; Shaheen, Ahmed; Grieco, Charlotte; d'Arienzo, Paolo D; Mina, Florentia; Czapla, Juliane A; Lawless, Aleigha R; Bongiovanni, Eleonora; Santaniello, Umberto; Zappi, Helena; Dulak, Dominika; Williamson, Andrew; Lee, Rebecca; Gupta, Avinash; Li, Caili; Si, Lu; Ubaldi, Martina; Yamazaki, Naoya; Ogata, Dai; Johnson, Rebecca; Park, Benjamin C; Jung, Seungyeon; Madonna, Gabriele; Hochherz, Juliane; Umeda, Yoshiyasu; Nakamura, Yasuhiro; Gebhardt, Christoffer; Festino, Lucia; Capone, Mariaelena; Ascierto, Paolo Antonio; Johnson, Douglas B; Lo, Serigne N; Long, Georgina V; Menzies, Alexander M; Namikawa, Kenjiro; Mandala, Mario; Guo, Jun; Lorigan, Paul; Najjar, Yana G; Haydon, Andrew; Quaglino, Pietro; Boland, Genevieve M; Sullivan, Ryan J; Furness, Andrew J S; Plummer, Ruth; Flaherty, Keith T.
Afiliación
  • Bai X; Department of Melanoma and Sarcoma, Peking University Cancer Hospital & Institute, China.
  • Shaheen A; Massachusetts General Hospital, USA.
  • Grieco C; Newcastle University Centre for Cancer, UK.
  • d'Arienzo PD; Skin Unit, The Royal Marsden NHS Foundation Trust, London, UK.
  • Mina F; Skin Unit, The Royal Marsden NHS Foundation Trust, London, UK.
  • Czapla JA; Skin Unit, The Royal Marsden NHS Foundation Trust, London, UK.
  • Lawless AR; Massachusetts General Hospital, USA.
  • Bongiovanni E; Massachusetts General Hospital, USA.
  • Santaniello U; Dermatologic Clinic, Department of Medical Sciences, University of Turin Medical School, Italy.
  • Zappi H; Dermatologic Clinic, Department of Medical Sciences, University of Turin Medical School, Italy.
  • Dulak D; Alfred Health, Australia.
  • Williamson A; Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
  • Lee R; The Christie NHS Foundation Trust, Manchester, UK.
  • Gupta A; Division of Cancer Sciences, University of Manchester and Christie NHS Foundation Trust, Manchester, UK.
  • Li C; The Christie NHS Foundation Trust, Manchester, UK.
  • Si L; Department of Melanoma and Sarcoma, Peking University Cancer Hospital & Institute, China.
  • Ubaldi M; Department of Melanoma and Sarcoma, Peking University Cancer Hospital & Institute, China.
  • Yamazaki N; University of Perugia, Italy.
  • Ogata D; Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Johnson R; Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Park BC; Melanoma Institute Australia, The University of Sydney; Faculty of Medicine and Health, The University of Sydney; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, Australia.
  • Jung S; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Madonna G; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Hochherz J; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics - Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy.
  • Umeda Y; Department of Dermatology, University Medical Center Hamburg-Eppendorf (UKE), University Skin Cancer Center, Hamburg, Germany.
  • Nakamura Y; Department of Skin Oncology/Dermatology, Comprehensive Cancer Center, Saitama Medical University International Medical Center, Saitama, Japan.
  • Gebhardt C; Department of Skin Oncology/Dermatology, Comprehensive Cancer Center, Saitama Medical University International Medical Center, Saitama, Japan.
  • Festino L; Department of Dermatology, University Medical Center Hamburg-Eppendorf (UKE), University Skin Cancer Center, Hamburg, Germany.
  • Capone M; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics - Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy.
  • Ascierto PA; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics - Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy.
  • Johnson DB; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics - Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy.
  • Lo SN; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Long GV; Melanoma Institute Australia, The University of Sydney; Faculty of Medicine and Health, The University of Sydney, North Sydney, NSW, Australia.
  • Menzies AM; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
  • Namikawa K; Melanoma Institute Australia, The University of Sydney; Faculty of Medicine and Health, The University of Sydney; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, Australia.
  • Mandala M; Melanoma Institute Australia, The University of Sydney; Faculty of Medicine and Health, The University of Sydney; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, Australia.
  • Guo J; Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Lorigan P; University of Perugia, Italy.
  • Najjar YG; Department of Melanoma and Sarcoma, Peking University Cancer Hospital & Institute, China.
  • Haydon A; Division of Cancer Sciences, University of Manchester and Christie NHS Foundation Trust, Manchester, UK.
  • Quaglino P; UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
  • Boland GM; Alfred Health, Australia.
  • Sullivan RJ; Dermatologic Clinic, Department of Medical Sciences, University of Turin Medical School, Italy.
  • Furness AJS; Massachusetts General Hospital, USA.
  • Plummer R; Massachusetts General Hospital, USA.
  • Flaherty KT; Skin Unit, The Royal Marsden NHS Foundation Trust, London, UK.
EClinicalMedicine ; 71: 102564, 2024 May.
Article en En | MEDLINE | ID: mdl-38572079
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: EClinicalMedicine Año: 2024 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: EClinicalMedicine Año: 2024 Tipo del documento: Article País de afiliación: China